Ancheng Qin

494 total citations
25 papers, 366 citations indexed

About

Ancheng Qin is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ancheng Qin has authored 25 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ancheng Qin's work include Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Ancheng Qin is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Ancheng Qin collaborates with scholars based in China. Ancheng Qin's co-authors include Jia‐Wei Feng, Jing Ye, Hua Pan, Zhen Qu, Yong Jiang, Yong Jiang, Li-Na Zhou, Xinwei Jiang, Yijie Lu and Yuan Gao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cell Death and Disease and American Journal of Clinical Pathology.

In The Last Decade

Ancheng Qin

24 papers receiving 365 citations

Peers

Ancheng Qin
Matthew Peach United States
Athanasios Bikas United States
Minghua Ge China
Eric Casal Ide Italy
Deguang Kong China
Alla Verlinsky United States
W. Zhang United States
Jiangsheng Huang China
Honggang Jiang China
Koji Sekikawa Japan
Matthew Peach United States
Ancheng Qin
Citations per year, relative to Ancheng Qin Ancheng Qin (= 1×) peers Matthew Peach

Countries citing papers authored by Ancheng Qin

Since Specialization
Citations

This map shows the geographic impact of Ancheng Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ancheng Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ancheng Qin more than expected).

Fields of papers citing papers by Ancheng Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ancheng Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ancheng Qin. The network helps show where Ancheng Qin may publish in the future.

Co-authorship network of co-authors of Ancheng Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Ancheng Qin. A scholar is included among the top collaborators of Ancheng Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ancheng Qin. Ancheng Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fu, Yue, et al.. (2023). Micro RNA-365-3p as a Tumor Suppressor in Gastric Cancer: Inhibition of NUCKS1-Mediated PI3K/AKT Signaling and Anti-Tumor Effects. Science of Advanced Materials. 15(4). 494–508. 2 indexed citations
3.
4.
Huang, Bo, et al.. (2021). Sinensetin flavone exhibits potent anticancer activity against drug-resistant human gallbladder adenocarcinoma cells by targeting PTEN/PI3K/AKT signalling pathway, induces cellular apoptosis and inhibits cell migration and invasion.. PubMed. 25(2). 1251–1256. 13 indexed citations
5.
Qin, Ancheng, et al.. (2021). Long Non-coding RNA RP11-395G23.3 Acts as a Competing Endogenous RNA of miR-124-3p to Regulate ROR1 in Anaplastic Thyroid Carcinoma. Frontiers in Genetics. 12. 673242–673242. 3 indexed citations
6.
Lu, Yijie, et al.. (2020). Modafinil ameliorated pancreatic injury and inflammation through upregulating SNIP1. General Physiology and Biophysics. 39(4). 383–392. 4 indexed citations
7.
Lu, Yijie, et al.. (2020). Role of miR-18a and miR-25 disruption and its mechanistic pattern in progression of liver cancer. 3 Biotech. 10(2). 74–74. 3 indexed citations
8.
Feng, Jia‐Wei, Jing Ye, Hua Pan, et al.. (2020). Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma. Frontiers in Endocrinology. 11. 553577–553577. 10 indexed citations
9.
Feng, Jia‐Wei, Zhen Qu, Ancheng Qin, et al.. (2020). Significance of multifocality in papillary thyroid carcinoma. European Journal of Surgical Oncology. 46(10). 1820–1828. 75 indexed citations
10.
Qin, Ancheng, et al.. (2020). Axin1 inhibits proliferation, invasion, migration and EMT of hepatocellular carcinoma by targeting miR-650.. PubMed. 12(3). 1114–1122. 11 indexed citations
11.
Qin, Ancheng, Hua Jin, Yu Song, et al.. (2020). The therapeutic effect of the BRD4-degrading PROTAC A1874 in human colon cancer cells. Cell Death and Disease. 11(9). 805–805. 43 indexed citations
12.
Feng, Jia‐Wei, Ancheng Qin, Jing Ye, et al.. (2019). Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma. Endocrine Pathology. 31(1). 67–76. 49 indexed citations
13.
Lu, Yijie, et al.. (2019). miR-1470 regulates cell proliferation and apoptosis by targeting ALX4 in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 522(3). 716–723. 9 indexed citations
14.
Qin, Ancheng, et al.. (2019). Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo. Cellular Physiology and Biochemistry. 52(4). 758–768. 20 indexed citations
15.
Ji, Weiping, Kailian Zheng, Bin Song, et al.. (2019). OCIAD1 promoted pancreatic ductal adenocarcinoma migration by regulating ATM. Pancreatology. 19(5). 751–759. 3 indexed citations
16.
Qin, Ancheng, et al.. (2019). Comparison on the Efficacy of Three Duct Closure Methods after Laparoscopic Common Bile Duct Exploration for Choledocholithiasis. Medical Science Monitor. 25. 9770–9775. 9 indexed citations
17.
18.
Lu, Yijie, et al.. (2017). Overexpression of RAB34 correlates with poor prognosis and tumor progression in hepatocellular carcinoma. Oncology Reports. 38(5). 2967–2974. 10 indexed citations
19.
Qin, Ancheng, et al.. (2015). Inhibition of STAT3/cyclinD1 pathway promotes chemotherapeutic sensitivity of colorectal caner. Biochemical and Biophysical Research Communications. 457(4). 681–687. 39 indexed citations
20.
Qin, Ancheng, et al.. (2010). [Intrahepatic transplantation of in vitro induced autologous bone marrow-derived liver stem cells in patients with posthepatitic cirrhosis].. PubMed. 30(3). 529–1. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew Peach Breakdown of academic impact, for papers by Athanasios Bikas Breakdown of academic impact, for papers by Minghua Ge Breakdown of academic impact, for papers by Eric Casal Ide Breakdown of academic impact, for papers by Deguang Kong Breakdown of academic impact, for papers by Alla Verlinsky Breakdown of academic impact, for papers by W. Zhang Breakdown of academic impact, for papers by Jiangsheng Huang Breakdown of academic impact, for papers by Honggang Jiang Breakdown of academic impact, for papers by Koji Sekikawa
Rankless by CCL
2026